Evidence map›Paper›PMID 40442740›Full record

ArticleDiabetology & metabolic syndrome2025

Evaluating the impact of metabolic indicators and scores on cardiovascular events using machine learning.

Guanmou Li, Cheng Luo, Teng Ge, Kunyang He, Miao Zhang, Jinlin Hu, Baoshi Zheng, Rongjun Zou, Xiaoping Fan

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guanmou Li *State Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China.
Cheng Luo *Department of Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Teng Ge *State Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China.
Kunyang He *State Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China.
Miao ZhangDepartment of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou, 510000, China.
Jinlin HuState Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China.
Baoshi ZhengDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. baoshizhengyx@163.com.
Rongjun ZouState Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China. zourj3@mail2.sysu.edu.cn.
Xiaoping FanState Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China. fukui-hanson@hotmail.com.

Funding

National Natural Science Foundation of China No.82300315
6 · The paper itself

Abstract

Cardiovascular diseases such as coronary artery disease, myocardial infarction, and heart failure impact millions of people annually globally and are a major cause of disease and death. This study explores the predictive capabilities of novel metabolic indices (TyG, HOMA-IR, TG/HDL-C, and VAI) for major adverse cardiovascular events (MACE) and analyzes their relationships with diabetes and cardiovascular risks. Using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2003 to 2018, we applied multiple machine learning algorithms to evaluate nine metabolic indicators including cholesterol levels, triglycerides, insulin, and waist circumference. Through cross-validation to validate model performance, the XGBoost algorithm demonstrated the most accurate performance in predicting cardiovascular outcomes, particularly for diseases like angina and heart failure. Additionally, SHAP value analysis confirmed the critical roles of waist circumference and METS-IR in predicting adverse cardiovascular events. Furthermore, we employed 100 machine learning algorithms to calculate the AUC values of metabolic indicators in predicting AP, CHD, HF, and MI, showing that METS-IR had the greatest contribution in these aspects. This research highlights the significance of metabolic indices in stratifying cardiovascular risks and presents potential avenues for targeted preventive strategies.

Indexed as

Angina pectorisCoronary diseaseHeart failureMetabolismMyocardial infarction

Identifiers

PMID40442740
PMCPMC12123715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.